DGAP-News: MediClin AG: Business development of MediClin in 2009
(firmenpresse) - MediClin AG / Final Results
26.03.2010 08:00
Dissemination of a Corporate News, transmitted by
DGAP - a company of EquityStory AG.
The issuer / publisher is solely responsible for the content of this announcement.
---------------------------------------------------------------------------
Frankfurt am Main, March 26, 2010 - The Management Board of MEDICLIN
Aktiengesellschaft (MediClin) said at this year's balance sheet press
conference. that he is satisfied with the results of the year 2009. ' The
effects of the global financial and economic crisis were less severe on
clinic operators than was originally assumed, allowing us to continue on
our chosen path in a manner unaffected by the downturn', said Dr. Ulrich
Wandschneider, CEO of MediClin.
Group sales increased by 3.0% - proposal of a dividend payment
MediClin has achieved sales of EUR 470.6 million (2008: EUR 456.8 million)
in the FY 2009. The Group operating result increased by 7.4 % or EUR 1.2
million to EUR 17.0 million (2008: EUR 15.8 million) and the result
attributable to shareholders of MediClin AG was EUR 10.3 million, after EUR
7.1 million in the previous year.
Based on the satisfactory development in 2009 and relatively stable
prospects for 2010 the Management Board and the Supervisory Board will
propose a dividend of EUR 0.05 per share for the 2009 financial year at the
Annual General Meeting on May 26, 2009.
The occupancy rate increased further in 2009
The occupancy rate of the Group rose from 86.2 % to 87.1 %. In total the
number of cases decreased slightly to be seen alongside with an increase in
nursing days. The occupancy rate in the post-acute segment went up to 87.5
% (2008: 87.0 %) and in the acute segment up to 83.7 % (2008: 81.5 %). Both
segments increased sales as well as segment results. In the post-acute
segment sales were raised by 3.2 % up to EUR 270.0 million (2008: EUR 261,6
million) and result by 20,7 % up to EUR 6.2 million (2008: EUR 5,1
million). In the acute segment sales increased by 2.5 % up to EUR 189.6
million (2008: EUR 185.0 million) and result by 9,0 % up to EUR 17.2
million (2008: 15,8 million). The share of sales contributed by the
business field nursing care amounts to EUR 11,3 million (2008: EUR 11,1
million) thus being up 2.4 % against previous year.
Cash flow and cash and cash equivalents allow external growth
Cash flow from operating activities rose to EUR 32,3 million (2008: EUR
21,5 million) in 2009. Cash and cash equivalents amounted to EUR 58,5
million (31.12.2008: EUR 57.4 million) an the end of the reporting period.
In 2009 investments were made in conversion and expansion measures and
modern medical equipment
In 2009 in addition to the three already operating medical care centres
(MVZ) new medical care centres were established. Gross additions to
property, plant and equipment totalling EUR 16.2 million mainly relate to
conversion and expansion measures. A total of EUR 4.2 million was invested
for modern medical equipment. Furthermore in the context of our long-term
strategy to save energy we have invested in the new acquisition of block
heat and power plant.
The number of employees (full-time employees) is slightly above the
previous years figure
The average number of employees in 2009, calculated on the basis of
full-time staff, was 5,834 (2008: 5,816 full-time staff).
For 2010 a stable development is expected
MediClin could increase its sales and results in 2009. In terms of the
number of beds, the Groupis one of the large providers of rehabilitation
services, and an operator of acute care facilities in Germany. The medical
service offer places emphasis on the neurology and psychological sciences,
orthopaedics, and specialised hospitals such as heart centres, clinics for
adiposity, diabetes or radiotherapy.
The ongoing financial crisis and the tense labour market, have had no
negative impact on MediClin's occupancy rates and business development in
the first two months of 2010.
For the 2010 financial year, the Management Board anticipates sales on the
previous year's level, as long as framework conditions in the industry do
not change drastically. Achieving a result comparable with the previous
year is intended, mainly through efficiency gains and stringent cost
management. In relation to external growth, acquisition efforts in the
acute sector are the main focus.
The annual report 2009 is available under www.mediclin.de in German und
English
About MediClin AG (Ticker: MED; ISIN: DE0006595101)
MediClin AG is a nation-wide clinic operator and large provider of services
in the area of Psycho- and Neurosciences as well as Orthopaedic. With 33
clinics and 7 nursing care facilities and 9 Medizinische Versorgungszentren
(medical care units) in 11 federal states MediClin has a total capacity of
approximately 7,900 beds. MediClins' facilities include acute care clinics,
i.e., general hospitals, special treatment facilities, specialised
hospitals and clinics for post-acute treatment and medical rehabilitation.
MediClin has approximately 8,000 employees.
Important notice:
This press release includes future-oriented statements which are based on
assumptions and estimates. While MediClin AG is of the opinion that these
assumptions and estimates are correct, the actual future developments and
actual future results may deviate from these assumptions and estimates due
to the impact of various factors such as changes in the economic conditions
in Germany, legal changes concerning the health system, changes relating to
cost providers' expense behaviour. MediClin does not assume liability and
gives no warranty that future developments and the income actually achieved
in the future will comply with the assumptions and estimates stated in this
press release.
26.03.2010 08:00 Ad hoc announcement, Financial News and Media Release distributed by DGAP. Medienarchiv atwww.dgap-medientreff.deandwww.dgap.de---------------------------------------------------------------------------
Language: English
Company: MediClin AG
Okenstraße 27
77652 Offenburg
Deutschland
Phone: +49 (0)781 488-189
Fax: +49 (0)781 488-184
E-mail: alexandra.muehr(at)mediclin.de
Internet: www.mediclin.de
ISIN: DE0006595101
WKN: 659510
Listed: Regulierter Markt in Frankfurt (PrimeStandard); Freiverkehr
in Berlin, München, Düsseldorf, Stuttgart, Hamburg
End of News DGAP News-Service
---------------------------------------------------------------------------
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 26.03.2010 - 03:00 Uhr
Sprache: Deutsch
News-ID 1012031
Anzahl Zeichen: 0
contact information:
Contact person:
Town:
Phone:
Kategorie:
Business News
Anmerkungen:
Diese Pressemitteilung wurde bisher 105 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"DGAP-News: MediClin AG: Business development of MediClin in 2009
"
steht unter der journalistisch-redaktionellen Verantwortung von
MediClin AG (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
